Embria to Present on Immune-Health Yeast at Experimental Biology Conference
The poster references trials on EpiCor that have demonstrated the ingredient’s ability to function as an immune-modulating agent.
On April 11 at the Experimental Biology Conference in Washington, DC,Embria Health Sciences (Ankeny, IA) will present a scientific poster on its yeast-based fermentate ingredient EpiCor.
Titled “Yeast-Based Fermentate Supplementation Significantly Reduces Inflammation in Two Separate In Vivo Models,” the poster also references three published, double-blind, placebo-controlled randomized trials on EpiCor that have demonstrated the ingredient’s ability to function as an immune-modulating agent by significantly reducing common cold/flu-like and allergic rhinitis symptoms.
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
